These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 26524704)

  • 1. Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration.
    Brilliant MH; Vaziri K; Connor TB; Schwartz SG; Carroll JJ; McCarty CA; Schrodi SJ; Hebbring SJ; Kishor KS; Flynn HW; Moshfeghi AA; Moshfeghi DM; Fini ME; McKay BS
    Am J Med; 2016 Mar; 129(3):292-8. PubMed ID: 26524704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levodopa Is Associated with Reduced Development of Neovascular Age-Related Macular Degeneration.
    Hyman MJ; Skondra D; Aggarwal N; Moir J; Boucher N; McKay BS; MacCumber MW; Lavine JA
    Ophthalmol Retina; 2023 Sep; 7(9):745-752. PubMed ID: 37146684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levodopa Positively Affects Neovascular Age-Related Macular Degeneration.
    Figueroa AG; Boyd BM; Christensen CA; Javid CG; McKay BS; Fagan TC; Snyder RW
    Am J Med; 2021 Jan; 134(1):122-128.e3. PubMed ID: 32628915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A G-Protein Coupled Receptor and Macular Degeneration.
    Figueroa AG; McKay BS
    Cells; 2020 Apr; 9(4):. PubMed ID: 32276449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decoding Race and Age-Related Macular Degeneration: GPR 143 Activity Is the Key.
    Tung D; McKay BS
    Adv Exp Med Biol; 2023; 1415():43-47. PubMed ID: 37440012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPR143 Signaling and Retinal Degeneration.
    Figueroa AG; McKay BS
    Adv Exp Med Biol; 2019; 1185():15-19. PubMed ID: 31884582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and treatment of age-related macular degeneration: an update for pharmacists.
    Marshall LL; Roach JM
    Consult Pharm; 2013 Nov; 28(11):723-37. PubMed ID: 24217192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell based therapies for age-related macular degeneration: The promises and the challenges.
    Nazari H; Zhang L; Zhu D; Chader GJ; Falabella P; Stefanini F; Rowland T; Clegg DO; Kashani AH; Hinton DR; Humayun MS
    Prog Retin Eye Res; 2015 Sep; 48():1-39. PubMed ID: 26113213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Age-related Macular Degeneration in the Japanese].
    Yoshimura N
    Nippon Ganka Gakkai Zasshi; 2016 Mar; 120(3):163-88; discussion 189. PubMed ID: 27164756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence of retinal pigment epithelial changes after macular translocation with 360 degrees peripheral retinectomy for geographic atrophy.
    Cahill MT; Mruthyunjaya P; Bowes Rickman C; Toth CA
    Arch Ophthalmol; 2005 Jul; 123(7):935-8. PubMed ID: 16009834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of circular RNA-mediated regulation of L-DOPA to improve wet age-related macular degeneration.
    Jia X; Sun Y; Wang T; Zhong L; Deng J; Zhu X
    Gene; 2023 Apr; 861():147247. PubMed ID: 36736867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histologic and Optical Coherence Tomographic Correlates in Drusenoid Pigment Epithelium Detachment in Age-Related Macular Degeneration.
    Balaratnasingam C; Messinger JD; Sloan KR; Yannuzzi LA; Freund KB; Curcio CA
    Ophthalmology; 2017 May; 124(5):644-656. PubMed ID: 28153442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annual rates of arterial thromboembolic events in medicare neovascular age-related macular degeneration patients.
    Alexander SL; Linde-Zwirble WT; Werther W; Depperschmidt EE; Wilson LJ; Palanki R; Saroj N; Butterworth SL; Ianchulev T
    Ophthalmology; 2007 Dec; 114(12):2174-8. PubMed ID: 18054636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing medications for treatment of age-related macular degeneration: Insights from novel approaches to data mining.
    Moir J; Aggarwal S; Skondra D
    Exp Biol Med (Maywood); 2023 May; 248(9):798-810. PubMed ID: 37452694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of retinal pigment epithelial tears after intravitreal ranibizumab injection for neovascular age-related macular degeneration.
    Cunningham ET; Feiner L; Chung C; Tuomi L; Ehrlich JS
    Ophthalmology; 2011 Dec; 118(12):2447-52. PubMed ID: 21872935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study.
    Klein R; Klein BE; Knudtson MD; Meuer SM; Swift M; Gangnon RE
    Ophthalmology; 2007 Feb; 114(2):253-62. PubMed ID: 17270675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration.
    Bhutto IA; McLeod DS; Hasegawa T; Kim SY; Merges C; Tong P; Lutty GA
    Exp Eye Res; 2006 Jan; 82(1):99-110. PubMed ID: 16019000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-DOPA is an endogenous ligand for OA1.
    Lopez VM; Decatur CL; Stamer WD; Lynch RM; McKay BS
    PLoS Biol; 2008 Sep; 6(9):e236. PubMed ID: 18828673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD).
    Rasmussen H; Chu KW; Campochiaro P; Gehlbach PL; Haller JA; Handa JT; Nguyen QD; Sung JU
    Hum Gene Ther; 2001 Nov; 12(16):2029-32. PubMed ID: 11727737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort.
    Wang JJ; Foran S; Smith W; Mitchell P
    Arch Ophthalmol; 2003 May; 121(5):658-63. PubMed ID: 12742843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.